Last reviewed · How we verify
NCT03457740
Supplement Study: Strength, Testosterone, Sexual Function, Quality of Life
NA trial testing Formula 1 in Muscular Weakness in 118 participants. Completed in 20 April 2018.
23 March 2018
Quick facts
| Lead sponsor | Appalachian State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 118 |
| Start date | 5 February 2018 |
| Primary completion | 23 March 2018 |
| Estimated completion | 20 April 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Formula 1
- Formula 2
- Placebo
Conditions studied
- Muscular Weakness — all drugs for Muscular Weakness →
- Sexual Behavior — all drugs for Sexual Behavior →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Appalachian State University
Who can join
Adults 40 to 70, male only, with Muscular Weakness or Sexual Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Decreased muscle mass (sarcopenia) and strength (dynapenia) are common during aging, with a rate of muscle mass loss that is approximately 6% per decade between 30 and 70 years of age. Muscle mass loss results in reduced strength and physical function (frailty), increased risk for falls and bone fractures, and decreased quality of life. The age-related decrease in testosterone plays a key role in the loss of muscle mass and strength for aging males. There is increasing interest in nutritional and exercise strategies to prevent aging-related losses in muscle mass and strength. Sexual dysfunction has a high prevalence among men (31%), and include erectile difficulties (10%), lack of interest in sex (9%), and inability to achieve orgasm (7%). There are multiple causes including low testosterone. There is growing interest in natural supplements, and this study will compare under double blind procedures two natural supplements with placebo (Men's Perfect Multi Formula and Andro Vitality) that have been formulated by Purity Products. The supplements contain micronutrients, plant extracts, and herbs, with the primary bioactives Rhaponticum carthamoides and magnesium. Rhaponticum carthamoides, commonly known as maral root or Russian leuzea, is a perennial herb that grows in South Siberia, and has been used to enhance muscular and sexual function, but more evidence from properly designed human trials is needed to determine both efficacy and safety. The purpose of this study using a randomized, parallel group design, is to evaluate the effect of two supplements relative to placebo on strength, serum free and total testosterone levels, sexual function, mood state, and quality of life compared to placebo over a 6-week period in 120 males.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03457740
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Appalachian State University trials
Trials by the same sponsor.
- NCT07413874 — Telehealth Music Therapy for Adults With Endocrine Disorder and Depression · NA · not yet recruiting
- NCT06495190 — Cognition, Flavonoids, Exercise, Gut Microbiome · NA · recruiting
- NCT06392360 — Betaine, Exercise Performance, and Gut Permeability · NA · completed
- NCT06204666 — Hemp Fiber Ingestion and Gut Permeability After Exercise · NA · completed
- NCT05907135 — Beet Supplementation, Exercise, Inflammation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03457740 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Appalachian State University
- Last refreshed: 4 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03457740.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing